Clinical Trials Logo

Gastroesophageal Reflux clinical trials

View clinical trials related to Gastroesophageal Reflux.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06457334 Recruiting - GERD Clinical Trials

Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)

Start date: January 1, 2024
Phase:
Study type: Observational

Evaluate the effect of H.pylori eradication on Gastroesophageal-reflux disease and symptoms improvement

NCT ID: NCT06430047 Recruiting - Clinical trials for Gastro Esophageal Reflux

Efficacy and Safety of EsoDuo®

Start date: November 25, 2022
Phase: Phase 4
Study type: Interventional

Clinical Trial to Evaluate the Effects of EsoDuo® in Controlling Reflux Symptoms Related to the Acid

NCT ID: NCT06391177 Recruiting - Clinical trials for Helicobacter Pylori Infection

A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily

Start date: June 3, 2024
Phase: Phase 1
Study type: Interventional

The primary objective is to determine the pharmacokinetics (PK) of vonoprazan in breast milk of healthy lactating women who have received vonoprazan administered once daily for 4 consecutive days.

NCT ID: NCT06329583 Recruiting - Dysphagia Clinical Trials

Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry

Start date: May 10, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to determine which position, maneuvers or combination thereof generates the highest pressure at the EGJ as assessed by high-resolution esophageal manometry and thus greater or more robust contraction of the diaphragm.

NCT ID: NCT06317675 Recruiting - Clinical trials for Gastro-oesophageal Reflux Disease

Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease

Start date: February 18, 2024
Phase: Phase 2
Study type: Interventional

To evaluate the effects of osteopathic manipulative treatment in patients affected by symptoms related to gastro-oesophageal reflux disease (GERD)

NCT ID: NCT06316167 Recruiting - Clinical trials for Gastroesophageal Reflux

Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease

Start date: March 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about incidence of postoperative gastroesophageal reflux disease in mandatory hiatoplasty performed during gastric sleeve surgery. The main question[s] it aims to answer are: - Incidence of postoperative GERD in patients undergoing gastric sleeve with mandatory hiatoplasty - Comparison of postoperative complication rates, including GERD Participants will answer a follow-up questionnaire, about postoperative quality of life

NCT ID: NCT06280664 Recruiting - Clinical trials for Gastro Esophageal Reflux

Efficacy Of Hiatal Closure For GERD

Start date: October 2, 2020
Phase:
Study type: Observational

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

NCT ID: NCT06268548 Recruiting - Clinical trials for Diaphragm Dysfunction

Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

This study was conducted to investigate Effect of manual diaphragmatic activation on diaphragm function in patients with gastroesophageal reflux disease

NCT ID: NCT06241183 Recruiting - GERD Clinical Trials

Famotidine and Antacids for Treatment of Dyspepsia

Start date: November 9, 2023
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare intravenous famotidine, an H2 receptor antagonist, and Maalox/ Mylanta, an oral antacid, in treatment of dyspepsia in the emergency department. The goal of this study is to reduce patients' pain based on the verbal numerical pain scale. The anticipated outcome is for pain levels in both groups to decrease. It is expected that antacids will improve symptoms more quickly and to a greater degree within an hour of taking medication based on the results of similar studies.

NCT ID: NCT06222177 Recruiting - Clinical trials for Gastro Esophageal Reflux

Thresholds of SLR Maneuver in Obese Patients

SLR obese
Start date: January 1, 2024
Phase:
Study type: Observational

There is an increasing interest in High resolution manometry (HRM) in the preoperative assessment of patients with obesity, in order to identify the best surgical option. Sleeve gastrectomy (SG) has been known to increase the risk of gastro-esophageal reflux disease (GERD). Different techniques have been recently developed and validated to offer to these patients protection against pathologic GERD after SG. A recent study found a significant correlation between straight leg raise (SLR) maneuver during HRM and a positive pH-study. However, these maneuver has not been validated in an obese population, therefore the normality cut-off remain unknown. A multicenter study with a large number of patients undergoing pre-operative assessment for bariatric surgery could provide a precise threshold to predict pathologic esophageal acid exposure time.